Cardiology - European Medical Journal

Continue

Cardiology

Filter
23 Aug 2016

Chronic Total Occlusion in Patients After Coronary Artery Bypass Grafting: A Review of Possible Interventions and Results With a Case Study

Within 10 years following a coronary artery bypass graft (CABG), only 60% of vein grafts and 90% of internal mammary artery (IMA) grafts remain patent.
EMJ
3 Mins
12 Jul 2016

A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes

Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
5 Apr 2016

Big Data and Cardiology: Time for Mass Analytics?

The dawn of the millennium coupled with developments in technology has led to the computerisation of information previously collected with paper and…
23 Nov 2015

Management of Blood Pressure Control: At the Cutting Edge

Prof Williams opened the symposium by discussing the current state of blood pressure (BP) control in Europe and the key barriers to improving BP control…
23 Nov 2015

When the Going Gets Tough, the Tough Get Going

Patients with elevated blood pressure (BP) represent a major problem for primary care physicians, not only because of the large number of these patients…
20 Oct 2015

Treatment of Hypertension in New Frontiers

This symposium provided an excellent forum to discuss the global burden of hypertension, its challenges and approaches to best management.
20 Oct 2015

New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalaemia

This educational symposium discussed advances in blocking the renin–angiotensin–aldosterone system (RAAS) for patients with chronic systolic heart failure..
20 Oct 2015

International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban

Rivaroxaban is a direct factor Xa inhibitor and a non-vitamin K antagonist (VKA) novel oral anticoagulant (NOAC) approved for a number of indications.